Outcome of Vitrectomy in Proliferative Diabetic Retinopathy Patients with Diabetic Nephropathy- A Retrospective Study at Tertiary Eye Centre, Telangana State, in South India.

Jeng CJ, Hsieh YT, Yang CM, et al. Diabetic retinopathy in patients with diabetic nephropathy: development and progression. PLoS One 2016;11(8):e0161897.    

Mian LS, Moin M, Afzal A. Diabetic retinopathy in patients with chronic kidney disease. Pak Armed Forces Med J 2019;69(3):625-30.          

Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin North Am 2004;88(4):1001-36.              

Chen YH, Chen HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced gfr among type 2 diabetic patients. Diabetes Care 2012;35(4):803-8.               

Mohan C, Muthukrishnan J, Mishra S, et al. Association of diabetic nephropathy with diabetic retinopathy in type 2 diabetes mellitus patients. International Journal of Advances in Medicine 2020;7(1):17-21.          

Byun SH, Ma SH, Jun KW, et al. Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea. PLoS One 2013;8(5):e62991.                 

Krakoff J, Lindsay RS, Looker HC, et al. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 2003;26(1):76-81.                             

Zhao XY, Song X, Chen YX. Antivascular endothelial growth factor agents pre-treatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analyses of randomized controlled trials. Br J Ophthalmology 2018;102(8):1077-85.   

Salvador FS, Franco RG, Cornejo GV, et al. Vitrectomy in diabetic patients with chronic kidney disease and diabetic retinopathy. EC Ophthalmology 2019;10(1):43-50.                 

Larrañaga-Fragoso P, Laviers H, McKechnie C, et al. Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.  Graefe's Archive for Clinical and Experimental Ophthalmology 2020;258(1):63-70.      

Niwa Y, Kakinoki M, Sawada T, et al. Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and non-vitrectomized macaque eyes. Invest Ophthalmol Vis Sci 2015;56(11):6501-5.